A rabies vaccine adjuvanted with saponins from leaves of the soap tree (Quillaja brasiliensis) induces specific immune responses and protects against lethal challenge

World Organisation for Animal Health, 2015 Starodubova, 2015, Rabies vaccines: current status and prospects for development, Mol Biol (Mosk), 49, 577, 10.1134/S0026893315040172 World Health Organization, 2013 Brazil Ministry of Health, 2015 Pan American Health Organization, 2015 Hicks, 2012, Developments in rabies vaccines, Clin Exp Immunol, 169, 199, 10.1111/j.1365-2249.2012.04592.x Bonito, 2004, Adverse reactions associated with a Fuenzalida-Palacios rabies vaccine: a quasi-experimental study, Rev Soc Bras Med Trop, 37, 7, 10.1590/S0037-86822004000100002 Spickler, 2003, Adjuvants in veterinary vaccines: modes of action and adverse effects, J Vet Intern Med, 17, 273, 10.1111/j.1939-1676.2003.tb02448.x Kauffmann, 2004, Constituents from leaves of Quillaja brasiliensis, Nat Prod Res, 18, 153, 10.1080/14786410310001608055 Kensil, 1991, Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex, J Immunol, 146, 431, 10.4049/jimmunol.146.2.431 Fleck, 2006, Adjuvant activity of Quillaja brasiliensis saponins on the immune responses to bovine herpesvirus type 1 in mice, Vaccine, 24, 7129, 10.1016/j.vaccine.2006.06.059 Silveira, 2011, Quillaja brasiliensis saponins are less toxic than Quil A and have similar properties when used as an adjuvant for a viral antigen preparation, Vaccine, 29, 9177, 10.1016/j.vaccine.2011.09.137 de Costa, 2014, Alternative inactivated poliovirus vaccines adjuvanted with Quillaja brasiliensis or Quil-A saponins are equally effective in inducing specific immune responses, PLOS ONE, 9, e105374, 10.1371/journal.pone.0105374 Cibulski, 2016, Quillaja brasiliensis saponins induce robust humoral and cellular responses in a bovine viral diarrhea virus vaccine in mice, Comp Immunol Microb, 45, 1, 10.1016/j.cimid.2016.01.004 De Costa, 2013, Accumulation of a bioactive triterpene saponin fraction of Quillaja brasiliensis leaves is associated with abiotic and biotic stresses, Plant Physiol Biochem, 66, 56, 10.1016/j.plaphy.2013.02.003 Mastrogiovanni, 2012 World Health Organisation, 1996 Reed, 1938, A simple method of estimating fifty per cent endpoints, Am J Epidemiol, 27, 493, 10.1093/oxfordjournals.aje.a118408 2001, vol. 1 Berger, 2000, Th1 and Th2 responses: what are they?, BMJ, 321, 424, 10.1136/bmj.321.7258.424 Mosmann, 1996, The expanding universe of T-cell subsets: Th1, Th2 and more, Immunol Today, 17, 138, 10.1016/0167-5699(96)80606-2 O’Garra, 1998, Cytokines induce the development of functionally heterogeneous T helper cell subsets, Immunity, 8, 275, 10.1016/S1074-7613(00)80533-6 Gupta, 1993, Adjuvants – a balance between toxicity and adjuvanticity, Vaccine, 11, 293, 10.1016/0264-410X(93)90190-9 Schijns, 2001, Activation and programming of adaptive immune responses by vaccine adjuvants, Vet Sci Tomorrow, 3, 1 Batista-Duharte, 2011, Progress in understanding adjuvant immunotoxicity mechanisms, Toxicol Lett, 203, 97, 10.1016/j.toxlet.2011.03.001 Shahbazi, 2015, Immunological comparison of DNA vaccination using two delivery systems against canine leishmaniasis, Vet Parasitol, 212, 130, 10.1016/j.vetpar.2015.07.005 Thakur, 2015, Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis, Parasitol Int, 64, 70, 10.1016/j.parint.2014.10.003 Koraka, 2014, A recombinant rabies vaccine expressing the trimeric form of the glycoprotein confers enhanced immunogenicity and protection in outbred mice, Vaccine, 32, 4644, 10.1016/j.vaccine.2014.06.058 Petrovsky, 2004, Vaccine adjuvants: current state and future trends, Immunol Cell Biol, 82, 488, 10.1111/j.0818-9641.2004.01272.x Sun, 2009, Advances in saponin-based adjuvants, Vaccine, 27, 1787, 10.1016/j.vaccine.2009.01.091 Fleck, 2009, Immunoadjuvant saponin production in seedlings and micropropagated plants of Quillaja brasiliensis, In Vitro Cell Dev Biol Plant, 45, 715, 10.1007/s11627-009-9222-x McGettigan, 2010, Experimental rabies vaccines for humans, Expert Rev Vaccines, 9, 1177, 10.1586/erv.10.105